These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 20933465)
1. The Goldilocks' problem of cancer medicines. Sullivan R; Purushotham AD Lancet Oncol; 2010 Nov; 11(11):1017-8. PubMed ID: 20933465 [No Abstract] [Full Text] [Related]
2. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077 [TBL] [Abstract][Full Text] [Related]
3. Consumer Protection Act and doctors. Govindan KS J Indian Med Assoc; 1994 Nov; 92(11):382-3. PubMed ID: 7890952 [No Abstract] [Full Text] [Related]
4. An outline for HIPAA compliance. Health Insurance Portability and Accountability Act. Lax JR Optometry; 2002 Nov; 73(11):711-7. PubMed ID: 12516801 [No Abstract] [Full Text] [Related]
5. [The Comprehensive Federal Health Agency may not be all powerful]. MMW Fortschr Med; 2006 Apr; 148(16):53, 55. PubMed ID: 16688951 [No Abstract] [Full Text] [Related]
6. Medical judgment and therapeutics. Somberg JC Am J Ther; 1999 Nov; 6(6):291-2. PubMed ID: 11329111 [No Abstract] [Full Text] [Related]
7. Are "off-labels" legal? Price EC Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136 [TBL] [Abstract][Full Text] [Related]
8. [Legal issues in the off-label use of drug medication in in pediatrics]. Poetsch J J Dtsch Dermatol Ges; 2006 May; 4(5):421-6. PubMed ID: 16686611 [No Abstract] [Full Text] [Related]
9. [Regulatory framework for prescription and recommendations for proper use]. Bouvenot G; Villani P Rev Prat; 2013 Oct; 63(8):1165-70. PubMed ID: 24298839 [No Abstract] [Full Text] [Related]
10. Generalized drug dispensing by physicians: an ethical dilemma. Breschi LC Md Med J; 1988 Nov; 37(11):875-6. PubMed ID: 3185161 [No Abstract] [Full Text] [Related]
11. Expanded access to Phase II clinical trials in oncology: a step toward increasing scientific validity and compassion. Marcee AK Food Drug Law J; 2008; 63(2):439-57. PubMed ID: 18561471 [No Abstract] [Full Text] [Related]
12. Demand-side policies to encourage the use of generic medicines: an overview. Dylst P; Vulto A; Simoens S Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):59-72. PubMed ID: 23402447 [TBL] [Abstract][Full Text] [Related]
13. Access control in healthcare: the methodology from legislation to practice. Ferreira A; Correia R; Chadwick D; Antunes L Stud Health Technol Inform; 2010; 160(Pt 1):666-70. PubMed ID: 20841770 [TBL] [Abstract][Full Text] [Related]
14. Taking a stand. What physicians are saying about legalizing marijuana. Minn Med; 2014 Apr; 97(4):14-7. PubMed ID: 24868926 [No Abstract] [Full Text] [Related]
15. Risk management and intrusions on medical practice: striking a balance. Enzi MB; Kennedy EM Health Aff (Millwood); 2007; 26(3):678-80. PubMed ID: 17485743 [TBL] [Abstract][Full Text] [Related]
16. Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme. Mellor JD; Van Koeverden P; Yip SW; Thakerar A; Kirsa SW; Michael M Intern Med J; 2012 Nov; 42(11):1224-9. PubMed ID: 22372936 [TBL] [Abstract][Full Text] [Related]
17. Making it legal: abortion providers' knowledge and use of abortion law in New South Wales and Queensland. de Costa C; Douglas H; Black K Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):184-9. PubMed ID: 23347292 [TBL] [Abstract][Full Text] [Related]
18. Pain and prejudice: the use of chronic narcotic therapy in medical practice. Crausman RS; McIntyre B Med Health R I; 2009 Mar; 92(3):111-2. PubMed ID: 19385389 [No Abstract] [Full Text] [Related]
19. Patterns of care for younger women with breast cancer. Osteen RT; Cady B; Friedman M; Kraybill W; Doggett S; Hussey D; Urist M; Chmiel J; Clive R; Winchester D J Natl Cancer Inst Monogr; 1994; (16):43-6. PubMed ID: 7999468 [No Abstract] [Full Text] [Related]
20. Keynote comment: Cancer drug pricing in the USA. Johnson DH Lancet Oncol; 2006 Jun; 7(6):444-5. PubMed ID: 16750490 [No Abstract] [Full Text] [Related] [Next] [New Search]